Werfen

Werfen, established in 1966 in Barcelona, Spain, is a family-owned leader in specialized in vitro diagnostics (IVD). With over 7,100 employees and €2.1 billion in revenue, the company operates in more than 30 countries, focusing on innovative clinical diagnostics for hospitals and independent laboratories. Its growth includes the establishment of IZASA, Biokit, and Instrumentación Científica, which laid the foundation for its current multinational presence. The company is organized into four main areas: Hemostasis, Acute Care Diagnostics, Autoimmunity, and Original Equipment Manufacturing (OEM). Werfen offers a range of products, including coagulation testing systems, blood gas analyzers, and autoimmune disease diagnostics. Their portfolio features diagnostic instruments, reagents, and automation tools like HemoCell™ and HemoHub™ for optimizing laboratory workflows. With strategic hubs in the USA and Spain, Werfen serves healthcare institutions globally, emphasizing precision and efficiency in patient care.